Smith & Nephew launched a product assurance program that will reimburse a healthcare facility for the cost of the TRIGEN INTERTAN Intertrochanteric Hip Fracture Nail if it fails.
Results from the SAKOS pivotal trial of Stryker's SpineJack® implantable fracture reduction system successfully demonstrated non-inferiority to balloon kyphoplasty (BKP), with an excellent risk/benefit profile for up to 12 months.